Pleiotropic effects of angiotensin II receptor blocker in hypertensive patients

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

Björn Dahlöf, Richard B. Devereux, Sverre E. Kjeldsen et al. · The Lancet · 2002 · 5.4K citations

Hypertension, Cardiovascular Disease, Endpoint Reduction +7

1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension

Guidelines Subcommittee · Journal of Hypertension · 1999 · 3.7K citations

Hypertension, Guidelines Subcommittee, Hypertension Guidelines +22

Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells.

Kathy K. Griendling, C A Minieri, Jeremy D. Ollerenshaw et al. · Circulation Research · 1994 · 2.7K citations · Full text

Lipid Peroxidation, Signaling Pathways, Ang Ii +19

Paradoxical Vasoconstriction Induced by Acetylcholine in Atherosclerotic Coronary Arteries

Paul L. Ludmer, Andrew P. Selwyn, Thomas Shook et al. · New England Journal of Medicine · 1986 · 2.4K citations

Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines.

Raffaele De Caterina, Peter Libby, Haibing Peng et al. · Journal of Clinical Investigation · 1995 · 1.8K citations · Full text

Nitric Oxide, Cell Adhesion, Cgmp Analogues +21